We’re Pleased to Announce Good News
It seems rare these days to find something positive and encouraging in the news.
Even within our dynamic industry, many of the headlines are about the bad actors
and unfortunate incidents.
So I’m glad to be able to inject some sunshine into the mix. Surveying the financial
progress across the healthcare territory, we are pleased to report that all signs are
go within the Top 100 companies. It’s no surprise that J&J took the top spot again,
and you’ll see in our By the Numbers article that it also scored high on the list of
Fortune’s Most Admired Companies, joined by several others in their own Top 100.
Also cheering is the news that 78% of our list saw revenue increases, compared to 62% last year and an
anemic performance under 50% the year before.
Also notable is the significant growth of the medical device sector. A full 93% of these companies
showed higher revenues, and Medtronic’s acquisition of Covidien under Medtronic plc has vaulted it
into the top ten. Other continuing trends include the emergence of a broad coterie of companies from
around the world. Just in the top ten, the US, Germany, Switzerland, France, England and Ireland are
represented. Of course Japan appears often on the list, and is joined by Israel, the Netherlands, Denmark, Canada, Spain, India, Sweden and South Africa.
The total revenue added by medical device was $42B, $16B by pharma and $6B by biotech. Going back
to the headlines elsewhere, we can see that healthcare still has a lot of work to do to advance its many
goals: improving care, reining in costs, fostering better communication among all interested parties, and
of course continuing to focus on outcomes. But from where we sit, the industry as a whole is healthy,
energetic and aimed in the right direction.
And always, please keep the feedback coming. It all goes to making the magazine better for all of us.
Cari Kraft, Publisher
Click to download to your mobile device of choice
TO GET TOP 100
CARI kRAf T